Cargando…

Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis

One to six percent of patients with microscopic colitis are refractory to medical treatment. The effect of faecal microbiota transplantation (FMT) in active collagenous colitis (CC) has, to the best of our knowledge, never been reported before. Here, we report the effect of repeated FMT in a patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Günaltay, Sezin, Rademacher, Lech, Hultgren Hörnquist, Elisabeth, Bohr, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323457/ https://www.ncbi.nlm.nih.gov/pubmed/28275312 http://dx.doi.org/10.3748/wjg.v23.i7.1319

Ejemplares similares

Enhanced Levels of Chemokines and Their Receptors in the Colon of Microscopic Colitis Patients Indicate Mixed Immune Cell Recruitment
por: Günaltay, Sezin, et al.
Publicado: (2015)

Reduced IL-37 Production Increases Spontaneous Chemokine Expressions in Colon Epithelial Cells
por: Günaltay, Sezin, et al.
Publicado: (2017)

An In Vitro Model to Evaluate the Impact of the Soluble Factors from the Colonic Mucosa of Collagenous Colitis Patients on T Cells: Enhanced Production of IL-17A and IL-10 from Peripheral CD4(+) T Cells
por: Kumawat, Ashok Kumar, et al.
Publicado: (2014)

Diagnosis and management of microscopic colitis: current perspectives
por: Bohr, Johan, et al.
Publicado: (2014)

Reduced T Cell Receptor Excision Circle Levels in the Colonic Mucosa of Microscopic Colitis Patients Indicate Local Proliferation rather than Homing of Peripheral Lymphocytes to the Inflamed Mucosa
por: Kumawat, Ashok Kumar, et al.
Publicado: (2013)

Patients With Microscopic Colitis Have Altered Levels of Inhibitory and Stimulatory Biomarkers in Colon Biopsies and Sera Compared to Non-inflamed Controls
por: Lushnikova, Alexandra, et al.
Publicado: (2021)

A Quantitative Study of the Mechanisms behind Thymic Atrophy in Gαi2-Deficient Mice during Colitis Development
por: Elgbratt, Kristina, et al.
Publicado: (2012)

Lack of effect of methotrexate in budesonide-refractory collagenous colitis
por: Münch, Andreas, et al.
Publicado: (2013)

Elevated fecal peptidase D at onset of colitis in Galphai2(-/-) mice, a mouse model of IBD
por: Bergemalm, Daniel, et al.
Publicado: (2017)

Faecal Microbiota Transplantation for Clostridium Difficile – a local perspective
por: Diamond, C, et al.
Publicado: (2017)

Faecal microbiota transplantation (FMT) with dietary therapy for acute severe ulcerative colitis
por: Costello, Samuel Paul, et al.
Publicado: (2020)

CD4(+)FoxP3(+) Regulatory T Cells from Gαi2(−/−) Mice Are Functionally Active In Vitro, but Do Not Prevent Colitis
por: Götlind, Yu-Yuan C., et al.
Publicado: (2011)

The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis
por: Carstens, Adam, et al.
Publicado: (2019)

Why is it so difficult to evaluate faecal microbiota transplantation as a treatment for ulcerative colitis?
por: Fairhurst, Natalie Grace, et al.
Publicado: (2018)

Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study
por: Jitsumura, Maki, et al.
Publicado: (2018)

Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis
por: Landy, J., et al.
Publicado: (2015)

A single faecal microbiota transplantation modulates the microbiome and improves clinical manifestations in a rat model of colitis
por: Lleal, Marina, et al.
Publicado: (2019)

Microscopic Colitis After Fecal Microbiota Transplant
por: Fasullo, Matthew J., et al.
Publicado: (2017)

Collagenous Colitis and Spondylarthropathy
por: Ben Abdelghani, Kaouther, et al.
Publicado: (2012)

Mucosal and faecal neutrophil gelatinase-associated lipocalin as potential biomarkers for collagenous colitis
por: Bakke, Ingunn, et al.
Publicado: (2021)

Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis
por: Rees, Nia Paddison, et al.
Publicado: (2022)

Faecal microbiota transplantation as a non-standard therapy for the treatment of Clostridioides difficile in an ulcerative colitis patient
por: Pendrasik, Karolina, et al.
Publicado: (2022)

Faecal Microbiota Transplantation Eradicated Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae from a Renal Transplant Recipient with Recurrent Urinary Tract Infections
por: Grosen, Anne Karmisholt, et al.
Publicado: (2019)

European consensus conference on faecal microbiota transplantation in clinical practice
por: Cammarota, Giovanni, et al.
Publicado: (2017)

Cancer Risk in Collagenous Colitis
por: Larsson, Johanna K., et al.
Publicado: (2019)

Free Faecal Water: Analysis of Horse Faecal Microbiota and the Impact of Faecal Microbial Transplantation on Symptom Severity
por: Laustsen, Louise, et al.
Publicado: (2021)

Faecal microbiota transplantation: a regulatory hurdle?
por: Verbeke, Frederick, et al.
Publicado: (2017)

Regulation, risk and safety of Faecal Microbiota Transplant
por: Merrick, Blair, et al.
Publicado: (2020)

Faecal microbiota transplantation: indications, evidence and safety
por: Soo, Wei Ting, et al.
Publicado: (2020)

Faecal Microbiota Transplantation and Chronic Kidney Disease
por: Bian, Ji, et al.
Publicado: (2022)

Faecal microbiota transplantation as a home therapy to frail older people
por: Jørgensen, Simon Mark Dahl, et al.
Publicado: (2020)

Incidental benefits after fecal microbiota transplant for ulcerative colitis
por: Mahajan, Ramit, et al.
Publicado: (2020)

Collagenous colitis and rheumatoid arthritis: is there a connection?
por: Wollheim, F, et al.
Publicado: (2003)

Oral faecal microbiota transplantation for the treatment of Clostridium difficile-associated diarrhoea in a dog: a case report
por: Sugita, Koji, et al.
Publicado: (2019)

Pseudomembranous Collagenous Colitis: A Case of Not-so-Microscopic Colitis
por: Grunwald, Douglas, et al.
Publicado: (2016)

The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis
por: Kump, P., et al.
Publicado: (2017)

A combination of the activation marker CD86 and the immune checkpoint marker B and T lymphocyte attenuator (BTLA) indicates a putative permissive activation state of B cell subtypes in healthy blood donors independent of age and sex
por: Axelsson, Susanne, et al.
Publicado: (2020)

Fecal microbiota transplantation in refractory ulcerative colitis – a case report
por: Moutinho, B. D., et al.
Publicado: (2019)

Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series
por: Lahtinen, Perttu, et al.
Publicado: (2017)

Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)—A Case Report
por: Merrick, Blair, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_grkrmrepdhiqq79c53ffdugmqp